Twist Bioscience insider sale: 31,348 shares valued at $1.01M
Rhea-AI Filing Summary
Form 144 notice shows an insider proposes to sell 31,348 shares of common stock, with an aggregate market value of $1,008,998.08, representing approximately 0.052% of the 60,360,925 shares outstanding. The shares were acquired through restricted stock vesting on 10/01/2025 and the approximate sale date is 10/06/2025. The filing lists prior insider sales in the past three months totaling 12,746 shares for gross proceeds of $348,121.10, with individual sale dates between 08/04/2025 and 10/02/2025. The filer attests there is no undisclosed material adverse information and notes the securities were received as compensation.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell a modest stake after restricted shares vested; recent sales have been small relative to outstanding stock.
The filing discloses a proposed sale of 31,348 shares valued at $1,008,998.08 with an approximate sale date of 10/06/2025. These shares were acquired via restricted stock vesting on 10/01/2025, and prior dispositions in the last three months totaled 12,746 shares for $348,121.10. As an insider sale notice under Rule 144, it documents a compliant, scheduled disposition following vesting and does not itself disclose operational changes.
The transaction size is small relative to total shares outstanding (0.052%), which reduces direct dilution or control concerns. Key things to watch in the near term are whether additional Form 4 or Form 144 filings appear and whether the insider shifts to larger, unscheduled sales over the next 90 days.